Results 1 to 10 of about 1,410,958 (292)

Overview of Long-Term Outcome in Adults with Systemic Right Ventricle and Transposition of the Great Arteries: A Review

open access: yesDiagnostics, 2023
The population of patients with a systemic right ventricle (sRV) in biventricular circulation includes those who have undergone an atrial switch operation for destro-transposition of the great arteries (d-TGA) and those with congenitally corrected ...
Francesca Bevilacqua   +7 more
doaj   +1 more source

Wearable cardioverter-defibrillator (life-vest): A feasible bridging treatment in adult congenital heart disease

open access: yesIndian Pacing and Electrophysiology Journal, 2022
Background: Wearable cardioverter-defibrillators (WCDs) are currently used in patients at temporarily heightened risk for sudden cardiac death (SCD) who are temporarily unable to receive an implantable cardioverter-defibrillator (ICD).
Berardo Sarubbi   +10 more
doaj   +1 more source

Pulmonary hypertension— a novel phenotypic hypothesis of Kabuki syndrome: a case report and literature review

open access: yesBMC Pediatrics, 2023
Background Pediatric pulmonary hypertension (PH) is a serious and rare disease that is often derived from genetic mutations. Kabuki syndrome (KS) is a chromosomal abnormality disease that has its origin in the mutation of lysine methyltransferase 2D ...
Xiao-xian Deng   +5 more
doaj   +1 more source

COVID-19 in congenital heart disease (COaCHeD) study

open access: yesOpen Heart, 2023
Background COVID-19 has caused significant worldwide morbidity and mortality. Congenital heart disease (CHD) is likely to increase vulnerability and understanding the predictors of adverse outcomes is key to optimising care.Objective Ascertain the impact
Ashish Chikermane   +35 more
doaj   +1 more source

Subcutaneous implantable cardioverter defibrillator in complex adult congenital heart disease. Results from the S-ICD “Monaldi Care” registry

open access: yesInternational Journal of Cardiology Congenital Heart Disease, 2021
Background: Implantable cardioverter defibrillators (ICD) are widely accepted therapy in congenital heart disease (CHD) patients at risk of life-threatening ventricular arrhythmias or sudden cardiac death (SCD).
Berardo Sarubbi   +13 more
doaj   +1 more source

Left Ventricular Physiology and Ventricular‐Vascular Interactions in Young Patients After Heart Transplantation

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background In patients after heart transplantation, systemic arterial hypertension and enhanced central aortic stiffness contribute to increased ventricular afterload, which might lead to graft dysfunction.
Heiner Latus   +12 more
doaj   +1 more source

VIRTUAL 3-D MODELLING OF AIRWAYS IN CONGENITAL HEART DEFECTS

open access: yesFrontiers in Pediatrics, 2016
The involvement of the airway is not uncommon in the presence of complex cardiovascular malformations. In these cases, a careful inspection of the relationship between the airway and the vasculature is paramount to plan the surgical procedure.
Simone Speggiorin   +3 more
doaj   +1 more source

Where the congenital heart disease meets the pulmonary arterial hypertension, FLNA matters: a case report and literature review

open access: yesBMC Pediatrics, 2020
Background Pediatric patients with genetic disorders have a higher incidence of pulmonary arterial hypertension (PAH) regardless of their heart defects. Filamin A (FLNA) mutation is recently recognized to be associated with pediatric pulmonary disorders,
Xiaoxian Deng   +9 more
doaj   +1 more source

Extracorporeal membrane oxygenation in paediatric cardiac surgery: 5-year single centre experience

open access: yesJournal of Cardiothoracic Surgery, 2023
Background Extracorporeal membrane oxygenation (ECMO) has become an integral part of paediatric cardiac surgery. We report the experience of a well-established ECMO service over 5 years.
Laurynas Bezuska   +5 more
doaj   +1 more source

Challenges of congenital heart disease in grown-up patients

open access: yesSwiss Medical Weekly, 2017
Nowadays, more than 90% of all children born with congenital heart disease (CHD) reach adult life. Although initially considered to be cured, the majority of them continue to need specialised follow-up because they require re-do interventions or are at
Markus Schwerzmann   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy